Advertisement

Index by author

September 01, 1988; Volume 34,Issue 3

  1. Manganiello, V C

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  2. Mcnamara, J O

    1. N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
      D W Bonhaus and J O McNamara
      Molecular Pharmacology September 1988, 34 (3) 250-255;

  3. Moss, J

    1. Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
      J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
      Molecular Pharmacology September 1988, 34 (3) 279-285;

  4. Motulsky, H J

    1. The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
      H Mueller, H J Motulsky and L A Sklar
      Molecular Pharmacology September 1988, 34 (3) 347-353;

  5. Mueller, H

    1. The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
      H Mueller, H J Motulsky and L A Sklar
      Molecular Pharmacology September 1988, 34 (3) 347-353;

  6. Murray, T F

    1. Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology September 1988, 34 (3) 334-339;

  7. Odajima, C

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;

  8. Ohishi, H

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  9. Ohmomo, Y

    1. Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
      T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
      Molecular Pharmacology September 1988, 34 (3) 377-387;

  10. Okabe, E

    1. The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
      E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
      Molecular Pharmacology September 1988, 34 (3) 388-394;
« Previous (Pages : 2 3 4 5 6 7 8 9 ... 9) Next »
Back to top

In this issue

Advertisement